As an organisation committed to improving the health of people who use drugs, INHSU knows that the policies, strategies and financial investments made by political leaders at all levels, from global, national and down to local governments are crucial to improving the lives of individuals, and the wellbeing of whole communities.
INHSU understands that it is vital to inform government action with community support to ensure evidence-based policy is enacted, enabling people to live healthier and more productive lives.
As an international leader in scientific knowledge exchange and knowledge translation focused on hepatitis C prevention and care among people who use drugs, it is clear that while the development of effective treatments are not enough, and the treatment and care of people who use drugs must be provided in a supportive environment that is underpinned by evidence based drug policies and approaches.
INHSU undertakes advocacy work to ensure that political decision makers, policy makers and funders have access to the best evidence about what works in relation to improving the health of people who use drugs, and are able to make informed decisions about drug user health. It also works to ensure that the community understands the issues facing people who use drugs, and to reduce the issues of stigma and discrimination.
Supporting frameworks and principles for action
INHSU strongly supports the frameworks of the Sustainable Development Goals and the WHO commitments to eliminate hepatitis C by 2030.
INHSU joins the global calls by policy experts to ensure that the principles of universal access to health care, harm minimization, public health must underpin approaches to drug user health and hepatitis C elimination. INHSU joins with global partners in calls to increase financial commitments to eliminate hepatitis C.
INHSU has focused it’s work on bringing together evidence around hepatitis C treatment, care and support of people who use drugs. As such, it has a significant evidence base about what works at a local, country and global level. It also has a body of knowledge regarding key issues and challenges that are hampering elimination efforts. In developing policy and advocacy positions, INHSU ensures that it is:
- Engaging with people who inject drugs to ensure that their experiences and perspectives are central to recommended actions and strategies
- Accessing information and knowledge around global directions and the work occurring within international multilateral organisational structures
- Locating the work to eliminate hepatitis C in the context of drug policy settings and a harm reduction approach
- Working with partners and stakeholders to ensure that it is accessing significant knowledge around the issues, challenges and opportunities at a country and regional level